The Case for Personalized Medicine, 3rd Edition Launch, Discussion and Reception 

The Personalized Medicine Coalition invites you to join us for a panel discussion of issues in personalized medicine at the launch of the 3^rd edition of PMC's signature publication, The Case for Personalized Medicine.

 Representing the diversity of the life sciences, the panel will feature:

• Moderator, Jennie Hunter-Cevera, Ph.D., Executive Vice President, RTI International
• Amy Abernethy, M.D., Director of the Duke Cancer Care Research Program
• Peter Collins, Ph.D., Vice President, Diagnostics, GlaxoSmithKline
• David King, Chief Executive Officer of the Laboratory Corporation of America (LabCorp)
• Eric Linsley, Managing Partner, Pappas Ventures

A cocktail reception will follow.

A block of hotel rooms has been reserved at the DoubleTree Suites by Hilton Hotel Raleigh-Durham.  Rooms are available for $119.00 per night plus tax.  Click here to make a reservation.